< Back to latest news & events

Awards

HGF ranked ‘Gold’ in the Financial Times special report

July 2019

HGF has been ranked in ‘Gold’ for:

  • Chemistry & pharmacy
  • Electrical engineering & physics
  • Mechanical engineering
  • Biotechnology, food & healthcare

And ‘Silver’ for:

  • Materials & nanotechnology
  • IT & software

HGF has been ranked in the ‘Gold’ and ‘Silver’ bands in The Financial Times special report ‘Europe’s Leading Patent Law Firms’ published on 9 July 2019.

The firm is one of the largest firms of IP specialists in Europe, with 21 offices across the UK, Ireland,  Germany, The Netherlands, Austria and Switzerland, and is internationally recognised by its peers across these 6 core areas of technology.

Kate Taylor – Head of the Life Sciences team commented, “I am delighted to receive this level of recognition from our clients and peer group. The team comprises some exceptional attorneys with in-depth experience from in-house roles and academia. We have a wealth of expertise across the life sciences spectrum, and of particular note is the firm’s technical and legal reputation in the area of CRISPR, led by Cath Coombes and Dr Claire Irvine.” 

Matt Dixon – Head of the Engineering team commented, “Receiving a gold ranking is testament to the exceptional quality of the team we have built across Europe. The work we are undertaking in the fields of energy and medical devices are particularly key to the growth we have experienced.”

Dr Andrew Wells – Head of the Chemistry team commented, “The chemical team has grown significantly in the last 5 years and our client base is international and representative of all the key areas of chemistry and pharmaceuticals. We have a large number of attorneys who have in-house backgrounds and this has been a strong benefit for advising clients on IP strategies in this often-complex sector.”

The research was undertaken by The FT’s partner Statista, the market research provider, who compiled the list based on the survey results. A special report featuring the final list and articles exploring the work and role of European patent attorneys appeared in print in the Financial Times and on FT.com on July 9 2019. The survey collected peer recommendations from patent attorneys registered with the European Patent Office (EPO) as well as names from clients who have used a patent law firm in one of the 38 member states of the Munich-based EPO.

As a firm we are committed to building strong client relationships and delivering outstanding service from our offices in Germany, The Netherlands, Switzerland, Austria, Ireland and the UK we are delighted to have been ranked in Gold and Silver. HGF has a clear strategic growth plan under the leadership of Paul Sanderson, CEO.

The firm’s expansion across Europe has continued in 2019 with the merger of Patronus IP which expanded HGF offices into Munich, Heidelberg and Salzburg. This year the firm has also opened Dublin. Unlike other multi-office IP firms, HGF is one integrated firm that draws on its expertise across all offices and across all our attorney teams of: Law, Trade Marks, Electronics, Engineering, Chemistry and Life Sciences to assemble multi-disciplinary client teams that work together to meet clients’ needs.

For the full report see here.

Latest updates

HGF Ranked #1 in the UK for Trade Mark Portfolios in the 2025 Trade Mark Filing Trends Report by Clarivate.

HGF has achieved the #1 ranking for the UK for trade mark portfolios in the newly released 2025 Trade mark Filing Trends report by Clarivate, recognising the firm as a …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

The Enlarged Board of Appeal has today issued its decision in seminal case G1/24.

G1/24, described as one of the most important cases in decades, relates to how claims of patents are to be interpreted by the Boards of Appeal and, by extension, all …

Read article

UPC’s Hamburg Local Division provides guidance on the extent to which a patent may be used as its own “lexicon”

Agfa NV v Gucci & Anors. [UPC_CFI_278/2023] – Hamburg Local Division of the UPC (Klepsch, Schilling, Sarlin) – 30 April 2025 While we await a decision on G1/24 from the …

Read article

MevoCem Nominated for the Earthshot Prize by CIPA

We’re delighted to share that our client, Material Evolution, has been nominated by the Chartered Institute of Patent Attorneys (CIPA) for the globally renowned Earthshot Prize, in recognition of their …

Read article

Agritech Thymes: Agritech 2030: Forecasting the Technologies Poised to Transform Farming

Whilst yet to recover to the levels of 2011-2021, where capital invested in agritech increased 20-fold, investor funding in agritech is starting to pick up, and 2025 is set to …

Read article

UPC delivers first judgment on Validity and Infringement of a Second Medical Use Claim

Sanofi Biotechnology SAS & Anor v Amgen, Inc., & Ors– Thomas, Thom, Kupecz and Dorland-Galliot – [UPC_CFI_505/2024] The Dusseldorf Local Division (LD) has delivered the UPC’s first Judgment on second …

Read article